| The response of CD24−/low/CD44+ breast cancer–initiating cells to radiation TM Phillips, WH McBride, F Pajonk Journal of the National Cancer Institute 98 (24), 1777-1785, 2006 | 1658 | 2006 |
| Metabolic state of glioma stem cells and nontumorigenic cells E Vlashi, C Lagadec, L Vergnes, T Matsutani, K Masui, M Poulou, ... Proceedings of the National Academy of Sciences 108 (38), 16062-16067, 2011 | 542 | 2011 |
| Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited F Pajonk, E Vlashi, WH McBride Stem cells 28 (4), 639-648, 2010 | 471 | 2010 |
| Radiation‐induced reprogramming of breast cancer cells C Lagadec, E Vlashi, L Della Donna, C Dekmezian, F Pajonk Stem cells 30 (5), 833-844, 2012 | 447 | 2012 |
| A sense of danger from radiation WH McBride, CS Chiang, JL Olson, CC Wang, JH Hong, F Pajonk, ... Radiation research 162 (1), 1-19, 2004 | 414 | 2004 |
| Cancer stem cells, cancer cell plasticity and radiation therapy E Vlashi, F Pajonk Seminars in cancer biology 31, 28-35, 2015 | 301 | 2015 |
| In vivo imaging, tracking, and targeting of cancer stem cells E Vlashi, K Kim, C Lagadec, LD Donna, JT McDonald, M Eghbali, ... Journal of the National Cancer Institute 101 (5), 350-359, 2009 | 300 | 2009 |
| Do erythropoietin receptors on cancer cells explain unexpected clinical findings? M Henke, D Mattern, M Pepe, C Bézay, C Weissenberger, M Werner, ... Journal of clinical oncology 24 (29), 4708-4713, 2006 | 287 | 2006 |
| Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials B C Potts, M X Albitar, K C Anderson, S Baritaki, C Berkers, B Bonavida, ... Current cancer drug targets 11 (3), 254-284, 2011 | 256 | 2011 |
| The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human … F Pajonk, J Himmelsbach, K Riess, A Sommer, WH McBride Cancer research 62 (18), 5230-5235, 2002 | 234 | 2002 |
| Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment C Lagadec, E Vlashi, L Della Donna, YH Meng, C Dekmezian, K Kim, ... Breast cancer research 12, 1-13, 2010 | 200 | 2010 |
| The role of the ubiquitin/proteasome system in cellular responses to radiation WH McBride, KS Iwamoto, R Syljuasen, M Pervan, F Pajonk Oncogene 22 (37), 5755-5773, 2003 | 163 | 2003 |
| Inhibition of NF-κB, clonogenicity, and radiosensitivity of human cancer cells F Pajonk, K Pajonk, WH McBride Journal of the National Cancer Institute 91 (22), 1956-1960, 1999 | 142 | 1999 |
| Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma P Evers, PP Lee, J DeMarco, N Agazaryan, JW Sayre, M Selch, F Pajonk BMC cancer 10, 1-7, 2010 | 136 | 2010 |
| Metabolic differences in breast cancer stem cells and differentiated progeny E Vlashi, C Lagadec, L Vergnes, K Reue, P Frohnen, M Chan, Y Alhiyari, ... Breast cancer research and treatment 146, 525-534, 2014 | 124 | 2014 |
| Erythropoietin for patients undergoing radiotherapy: a pilot study M Henke, R Guttenberger, A Barke, F Pajonk, R Pötter, H Frommhold Radiotherapy and oncology 50 (2), 185-190, 1999 | 116 | 1999 |
| Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses F Pajonk, WH McBride Radiotherapy and Oncology 59 (2), 203-212, 2001 | 115 | 2001 |
| Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition F Pajonk, K Pajonk, WH McBride International Journal of Radiation Oncology* Biology* Physics 47 (4), 1025-1032, 2000 | 103 | 2000 |
| The future of radiobiology DG Kirsch, M Diehn, AH Kesarwala, A Maity, MA Morgan, JK Schwarz, ... JNCI: Journal of the National Cancer Institute 110 (4), 329-340, 2018 | 102 | 2018 |
| Effects of recombinant erythropoietin on breast cancer-initiating cells TM Phillips, K Kim, E Vlashi, WH McBride, F Pajonk Neoplasia 9 (12), 1122-1129, 2007 | 99 | 2007 |
Chann LagadecAssociate Researcher INSERMCorreu electrònic verificat a inserm.fr
